Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Julia Stowe, Chris Robertson, Elise Tessier, Ruth Simmons, Simon Cottrell, Richard Roberts, Mark O’Doherty, Kevin Brown, Claire Cameron, Diane Stockton, Jim McMenamin, Mary Ramsay
doi: https://doi.org/10.1101/2021.03.01.21252652
Jamie Lopez Bernal
1Public Health England, London, United Kingdom
2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
3NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, United Kingdom
Nick Andrews
1Public Health England, London, United Kingdom
2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
Charlotte Gower
1Public Health England, London, United Kingdom
Julia Stowe
1Public Health England, London, United Kingdom
Chris Robertson
4University of Strathclyde, Glasgow, United Kingdom.
Elise Tessier
1Public Health England, London, United Kingdom
Ruth Simmons
1Public Health England, London, United Kingdom
Simon Cottrell
5Public Health Wales, Cardiff, United Kingdom.
Richard Roberts
5Public Health Wales, Cardiff, United Kingdom.
Mark O’Doherty
6Public Health Agency Northern Ireland, Belfast, United Kingdom.
Kevin Brown
1Public Health England, London, United Kingdom
Claire Cameron
7Public Health Scotland, Glasgow, United Kingdom.
Diane Stockton
7Public Health Scotland, Glasgow, United Kingdom.
Jim McMenamin
7Public Health Scotland, Glasgow, United Kingdom.
Mary Ramsay
1Public Health England, London, United Kingdom
2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
Posted March 02, 2021.
Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Julia Stowe, Chris Robertson, Elise Tessier, Ruth Simmons, Simon Cottrell, Richard Roberts, Mark O’Doherty, Kevin Brown, Claire Cameron, Diane Stockton, Jim McMenamin, Mary Ramsay
medRxiv 2021.03.01.21252652; doi: https://doi.org/10.1101/2021.03.01.21252652
Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Julia Stowe, Chris Robertson, Elise Tessier, Ruth Simmons, Simon Cottrell, Richard Roberts, Mark O’Doherty, Kevin Brown, Claire Cameron, Diane Stockton, Jim McMenamin, Mary Ramsay
medRxiv 2021.03.01.21252652; doi: https://doi.org/10.1101/2021.03.01.21252652
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12634)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4494)
- Geriatric Medicine (411)
- Health Economics (718)
- Health Informatics (2877)
- Health Policy (1059)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4264)
- Nursing (228)
- Nutrition (626)
- Oncology (2232)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6845)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)